Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin intraocular infusion for postoperative inflammation after cataract surgery in diabetic patients
ACTRN12613000775718Phase 4Completed
- Sponsor
- Ozgur Ilhan
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of enoxaparin in post-operative inflammation (2 arms), sponsored by Ozgur Ilhan. Primary endpoint: Anterior segment inflammation. Started Aug 2010; status: completed.
02
Drugs
enoxaparin
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on ACTRN12613000775718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000775718.